CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations

Clinical and Experimental Allergy

Volumn 44, Issue 7, 2014, Pages 930-939

  Rohde, G ^a,b   Message, S D ^a,c   Haas, J J ^a   Kebadze, T ^a   Parker, H ^a   Laza Stanca, V ^a   Khaitov, M R ^a,d   Kon, O M ^c   Stanciu, L A ^a   Mallia, P ^a,c   Edwards, M R ^a   Johnston, S L ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d INSTITUTE OF IMMUNOLOGY   (Russian Federation)

Author keywords

Airway epithelium; Infection control; Innate immunity; Neutrophil biology; Respiratory infection

Indexed keywords

ALPHA CHEMOKINE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; ELAFIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; POLYPEPTIDE ANTIBIOTIC AGENT; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; ANTIMICROBIAL CATIONIC PEPTIDE; TIPRELESTAT;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; EXPERIMENTAL ASTHMA; FEMALE; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOVIRUS; STUDY DESIGN; ADOLESCENT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CHEMISTRY; COMPLICATION; CYTOLOGY; DISEASE COURSE; IMMUNOLOGY; LUNG FUNCTION TEST; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PICORNAVIRUS INFECTION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; ELAFIN; FEMALE; HUMANS; MALE; NEUTROPHILS; PICORNAVIRIDAE INFECTIONS; RESPIRATORY FUNCTION TESTS; RHINOVIRUS; YOUNG ADULT;

EID: 84904670489     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12313     Document Type: Article

References (39)

1. Corne JM, Marshall C, Smith S et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359:831-4.
2. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982-6.
3. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
4. Papadopoulos NG, Bates PJ, Bardin PG et al. Rhinoviruses infect the lower airways. J Infect Dis 2000; 181:1875-84.
5. Message SD, Laza-Stanca V, Mallia P et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA 2008; 105:13562-7.
6. Lehrer RI. Primate defensins. Nat Rev Microbiol 2004; 2:727-38.
7. Grunberg K, Smits HH, Timmers MC et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997; 156:609-16.
8. Qiu Y, Zhu J, Bandi V, Guntupalli KK, Jeffery PK. Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma. Thorax 2007; 62:475-82.
9. Rice WG, Ganz T, Kinkade JM Jr, Selsted ME, Lehrer RI, Parmley RT. Defensin-rich dense granules of human neutrophils. Blood 1987; 70:757-65.
10. Proud D. The role of defensins in virus-induced asthma. Curr Allergy Asthma Rep 2006; 6:81-5.
11. Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000; 105(6 Pt 1):1169-77.
12. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19:68-75.
13. Travis SM, Anderson NN, Forsyth WR et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000; 68:2748.
14. Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clin Sci (Lond) 2006; 110:21-35.
15. Rohde G, Message S, Laza-Stanca V, Mallia P, Edwards MR, Johnston SL. Increase in alpha-defensins during rhinovirus-induced experimental asthma exacerbations. Eur Respir J 2006; 28(Suppl. 50):154s.
16. Sterk PJ, Fabbri LM, Quanjer PH et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:53-83.
17. Bardin PG, Sanderson G, Robinson BS, Holgate ST, Tyrrell DA. Experimental rhinovirus infection in volunteers. Eur Respir J 1996; 9:2250-5.
18. Turner RB, Weingand KW, Yeh CH, Leedy DW. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 1998; 26:840-6.
19. Woodruff PG, Khashayar R, Lazarus SC et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001; 108:753-8.
20. Zambrano JC, Carper HT, Rakes GP et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol 2003;111(5, Suppl. 1):1008-16.
21. Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and alpha -defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96:3086-93.
22. Khine AA, Del SL, Vaschetto R et al. Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 2006; 107:2936-42.
23. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96:549-57.
24. Falco A, Brocal I, Perez L, Coll JM, Estepa A, Tafalla C. In vivo modulation of the rainbow trout (Oncorhynchus mykiss) immune response by the human alpha defensin 1, HNP1. Fish Shellfish Immunol 2008; 24:102-12.
25. Owen C. Chemokine receptors in airway disease: which receptors to target? Pulm Pharmacol Ther 2001; 14:193-202.
26. Nagarkar DR, Wang Q, Shim J et al. CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J Immunol 2009; 183:6698-707.
27. Chapman RW, Phillips JE, Hipkin RW, Curran AK, Lundell D, Fine JS. CXCR2 antagonists for the treatment of pulmonary disease. Pharmacol Ther 2009; 121:55-68.
28. Chapman RW, Minnicozzi M, Celly CS et al. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther 2007; 322:486-93.
29. Nguyen EK, Nemerow GR, Smith JG. Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol 2010; 84:4041-9.
30. Buck CB, Day PM, Thompson CD et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci USA 2006; 103:1516-21.
31. Seidel A, Ye Y, de Armas LR et al. Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One 2010; 5:e9737.
32. Gropp R, Frye M, Wagner TO, Bargon J. Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapy. Hum Gene Ther 1999; 10:957-64.
33. Yang D, Chen Q, Chertov O, Oppenheim JJ. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000; 68:9-14.
34. Brogden KA, Heidari M, Sacco RE et al. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 2003; 18:95-9.
35. Biragyn A, Ruffini PA, Leifer CA et al. Toll-like receptor 4-dependent activation of dendritic cells by beta -defensin 2. Science 2002; 298:1025-9.
36. Biragyn A, Surenhu M, Yang D et al. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 2001; 167:6644-53.
37. Rowe T, Leon AJ, Crevar CJ et al. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010; 401:257-65.
38. Di Stefano A, Caramori G, Gnemmi I et al. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax 2009; 64:968-75.
39. Pizzichini MM, Pizzichini E, Efthimiadis A et al. Asthma and Natural Colds. Inflammatory Indices in Induced Sputum: A Feasibility Study. Am J Respir Crit Care Med 1998; 158:1178-84.